Physician profile
Michael J Daly
NPI 1194721753
$573.41
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $565 · 2022: $8.17.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $120.67 | 2019 | |
| Collegium Pharmaceutical, INC. | $78.21 | 2019 | |
| Daiichi Sankyo INC. | $51.33 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $49.58 | 2019 | |
| Si-Bone, INC. | $40.03 | 2019 | |
| Tersera Therapeutics LLC | $31.94 | 2019 | |
| Sentynl Therapeutics, INC. | $29.67 | 2019 | |
| Novartis Pharmaceuticals Corporation | $22.75 | 2019 | |
| Pacira Therapeutics, INC. | $21.37 | 2019 | |
| Scilex Pharmaceuticals INC. | $20.63 | 2019 | |
| Depuy Synthes Sales INC. | $20.54 | 2019 | |
| Acelrx Pharmaceuticals, INC. | $18.05 | 2019 | |
| Fidia Pharma USA INC. | $15.82 | 2019 | |
| Shionogi INC | $15.10 | 2019 | |
| Horizon Therapeutics Plc | $15.09 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $14.46 | 2019 | |
| Ambu INC. | $8.17 | 2022 |
1 company reported research payments only; those appear in the research section below.
Research and ownership
$10,512.81 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Daly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.